Dimerix Limited is a clinical-stage biopharmaceutical company developing innovative therapies for unmet medical needs, particularly in kidney and respiratory diseases.
Ticker code: DXB
Sector: Healthcare | Industry: Biotechnology | Website: https://dimerix.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $309,204,331 | $241,018,004 | 600396776 | 78.36 | $242,299,620 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $13,208,729 | $68,283,808 | $97,481 | -90.9 | None | -516.2 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Positive | 4.4 | $200,106 | $734,960 | 0.2 | 0.8 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | 1999-09-24 | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $0.515 | -1.9 | None | 1.0 | -8.8 | 7.3 | 27.2 |
DXB Price Chart with Volume and 3EMA
DXB Short Positions
Click HERE to understand why the above moving averages have been chosen.